MPN Watch

Scan run #28

Started 20-sep-2026 22:00 · finished 20-sep-2026 22:29 · triggered by cron

Items fetched Relevant Stored New pages
56 15 15 11

New pages this run

The "11" New pages column above counts new wiki pages created across every area (the column name new_mechanisms is a v1 holdover — it covers mechanisms + treatments + subtypes + transplant-timing + symptoms + lifestyle).

Area Page Mentions to date
Disease Subtypes Advanced systemic mastocytosis (AdvSM) 1
Stem Cell Transplant Decisions CLAG-M or FLAG-Ida + TBI reduced-intensity conditioning 1
Stem Cell Transplant Decisions FLAMSA + Treosulfan + Venetoclax conditioning (FLAMSAClax) 1
Treatments Aspirin in MPN 1
Treatments Bezuclastinib (CGT9486) 1
Treatments CLAG-M or FLAG-Ida + TBI reduced-intensity conditioning 1
Treatments Canakinumab 1
Treatments Direct oral anticoagulants (DOACs) in MPN thrombosis 1
Treatments Emavusertib 1
Treatments RVU120 (investigational agent for MF) 1
Treatments Venetoclax + FLAMSA + Treosulfan conditioning (FLAMSAClax) 1

Dynamic queries this run

SPEC-V2.4 — the expander proposes new searches for pages that have crossed their mention threshold. They run on subsequent scans alongside the static spec queries.

Metric Count
New queries proposed 10
Active queries that fired 1
Items pulled in via dynamic queries 5
Queries auto-demoted this run 0

Proposed this run

PageSourceQueryRationaleStatus
Clonal hematopoiesis pubmed ("bomedemstat"[Title/Abstract] OR "IMG-7289"[Title/Abstract] OR "MK-3543"[Title/Abstract] OR "LSD1 inhibitor"[Title/Abstract] OR "LSD1 inhibition"[Title/Abstract]) AND ("clonal hematopoiesis"[Title/Abstract] OR CHIP[Title/Abstract] OR splenomegaly[Title/Abstract] OR "spleen volume"[Title/Abstract] OR "allele burden"[Title/Abstract] OR "clonal fitness"[Title/Abstract] OR "mutant clone"[Title/Abstract]) Targets bomedemstat/LSD1 inhibition linked to splenomegaly and clonal fitness endpoints, including non-MPN CHIP/myeloid contexts the existing MPN-only bomedemstat query misses. active
Inflammatory cytokine signaling pubmed ("NK cell"[Title/Abstract] OR "NK cells"[Title/Abstract] OR "natural killer"[Title/Abstract]) AND (interferon[Title/Abstract] OR ropeginterferon[Title/Abstract] OR "type-I interferon"[Title/Abstract] OR "type I interferon"[Title/Abstract]) AND ("polycythemia vera"[Title/Abstract] OR myelofibrosis[Title/Abstract] OR myeloproliferative[Title/Abstract] OR JAK2[Title/Abstract] OR fatigue[Title/Abstract]) Targets the IFN–NK clone-clearance mechanism and fatigue link for ropeginterferon that existing ropeginterferon, cytokine, and QoL queries do not specifically cover. active
JAK-STAT signaling pubmed "INCA033989"[Title/Abstract] AND ("splenomegaly"[Title/Abstract] OR "spleen volume"[Title/Abstract] OR "spleen size"[Title/Abstract] OR "spleen response"[Title/Abstract] OR "JAK-STAT"[Title/Abstract] OR pSTAT5[Title/Abstract] OR MPL[Title/Abstract]) Targets INCA033989 with splenomegaly and CALR–MPL–JAK-STAT mechanism/readout terms rather than disease labels, catching confirming or disconfirming spleen and pathway evidence in adjacent models the existing drug+MPN query can miss. active
Diet and Nutrition pubmed ("Mediterranean diet"[Title/Abstract] OR "anti-inflammatory diet"[Title/Abstract] OR "dietary pattern"[Title/Abstract] OR "nutritional intervention"[Title/Abstract] OR "dietary iron"[Title/Abstract] OR "iron intake"[Title/Abstract] OR nutrition[Title/Abstract]) AND ("myeloproliferative"[Title/Abstract] OR "polycythemia vera"[Title/Abstract] OR myelofibrosis[Title/Abstract] OR "essential thrombocythemia"[Title/Abstract] OR MPN[Title/Abstract]) Catches diet-pattern, Mediterranean/anti-inflammatory nutrition, and dietary iron literature for MPNs not covered by the existing supplement/antioxidant or hepcidin-pathway queries. active
Azacitidine (5-AZA) pubmed ("azacitidine"[Title/Abstract] OR "5-azacitidine"[Title/Abstract] OR "5-AZA"[Title/Abstract] OR Vidaza[Title/Abstract]) AND (myeloproliferative[Title/Abstract] OR myelofibrosis[Title/Abstract] OR "polycythemia vera"[Title/Abstract] OR "essential thrombocythemia"[Title/Abstract] OR CMML[Title/Abstract] OR "chronic myelomonocytic"[Title/Abstract] OR "MDS/MPN"[Title/Abstract] OR JMML[Title/Abstract]) Targets azacitidine/5-AZA/Vidaza specifically (not the broader epigenetic/decitabine bundle already running) and adds CMML, JMML, and MDS/MPN overlap terms that match tagged findings and are missing from the existing azacitidine-containing query. active
Fludarabine + Busulfan conditioning regimen pubmed ("fludarabine"[Title/Abstract] AND "busulfan"[Title/Abstract]) AND (conditioning[Title/Abstract] OR "reduced-intensity"[Title/Abstract] OR RIC[Title/Abstract] OR "stem cell transplantation"[Title/Abstract]) AND (myelofibrosis[Title/Abstract] OR "myeloproliferative"[Title/Abstract] OR MPN[Title/Abstract] OR "polycythemia vera"[Title/Abstract]) Targets fludarabine/busulfan conditioning specifically for MPN allotransplant, which no existing static or dynamic query covers. active
INCA033989 (novel investigational agent for MPN) pubmed INCA033989[Title/Abstract] AND (myeloproliferative OR myelofibrosis OR "essential thrombocythemia" OR MPN OR CALR) Targets the specific investigational agent INCA033989 by name, which no existing static or dynamic query covers, while broader mutant-CALR queries miss drug-specific papers. active
Inflammatory cytokine signaling pubmed ("NLRP3"[Title/Abstract] OR inflammasome[Title/Abstract] OR "interleukin-1"[Title/Abstract] OR "IL-1beta"[Title/Abstract] OR "IL-1β"[Title/Abstract] OR "NF-kappaB"[Title/Abstract] OR "NF-κB"[Title/Abstract]) AND ("myeloproliferative"[Title/Abstract] OR myelofibrosis[Title/Abstract] OR "polycythemia vera"[Title/Abstract] OR "essential thrombocythemia"[Title/Abstract]) Captures upstream inflammasome/IL-1/NF-κB inflammatory signaling in MPN that existing IL-6/IL-8/TNF and drug-tied canakinumab/anakinra queries miss. active
CALR mutations pubmed ("mutant calreticulin"[Title/Abstract] OR "mutant CALR"[Title/Abstract] OR "CALR-directed"[Title/Abstract] OR "anti-CALR"[Title/Abstract] OR "CALR neoantigen"[Title/Abstract]) AND (myeloproliferative OR myelofibrosis OR "essential thrombocythemia" OR MPN) Pulls mutant-CALR biology and CALR-directed/immunotherapy papers in MPN without requiring exon-9/type-1/type-2/MPL terms already used by the existing CALR dynamic query. active
JAK-STAT signaling pubmed ("STAT5"[Title/Abstract] OR "STAT3"[Title/Abstract] OR pSTAT5[Title/Abstract] OR "STAT phosphorylation"[Title/Abstract]) AND ("JAK2"[Title/Abstract] OR "Janus kinase"[Title/Abstract]) AND (myeloproliferative[Title/Abstract] OR myelofibrosis[Title/Abstract] OR "polycythemia vera"[Title/Abstract] OR "essential thrombocythemia"[Title/Abstract]) Catches STAT3/STAT5-centric JAK2 pathway mechanism papers that omit the exact phrase JAK-STAT already covered by the existing dynamic query. active

build build 612 · 69ce4cf-dirty · 2026-11-11